Background
Methods
Study area
Target population
Inclusion and exclusion criteria
Study design
Sample size calculations
Sampling strategy
Data collection
Laboratory methods
Data management
Data analysis
Results
Table 1: Descriptive demographic characteristics of the study population (N = 476)
Characteristics | Frequencies (%) |
---|---|
Country of Origin | |
Uganda | 37(7.8) |
SSD | 435(91.4) |
Rwanda | 1(0.21) |
Congo | 2(0.42) |
Burundi | 1(0.21) |
Length of stay | |
< 12 Months | 103(21.6) |
12-24 Months | 128(26.9) |
> 24 months | 210(44.1) |
Unknown | 35(7.4) |
Level of Education | |
Primary | 215(45.2) |
Secondary | 61(12.8) |
Tertiary | 18(3.78) |
Unknown | 175(38.2) |
Wash hands before eating | |
No | 05(1.05) |
Yes | 471(98.9) |
If yes | |
Water Only | 98(20.8) |
Water and Soap | 373(79.2) |
Source of drinking water | |
Tap water | 201(42.3) |
Borehole | 267(56.09) |
Stream | 2(0.42) |
Protected well | 3(0.63) |
Unprotected | 3(0.63) |
Ever diagnosed with malaria | |
No | 15(3.15) |
Yes | 432(90.8) |
Don’t know | 29(6.1) |
Child ever slept under mosquito net | |
No | 22(4.6) |
Yes | 454(95.4) |
Source of LLINs | |
Gov’t | 50(10.6) |
NGO | 251(52.7) |
Don’t Know | 175(36.7) |
Washing hands after using toilet | |
No | 73(16.4) |
Yes | 364(83.3) |
Study related factor | Frequencies (%) |
---|---|
Anti-Helminths Medication | |
No | 117(24.6) |
Yes | 255(53.6) |
Didn’t Know | 104(21.9) |
MUAC (cm) median | |
< 11.5 | 0 (0.0) |
> 11.5 | 18.8(100) |
Haemoglobin(g/dl) median | |
< 11.5 | 11.41(16.7) |
> 11.5 | 13.6 (83.3) |
Parasitic Infection | |
Single Infection | 300 (63.03) |
Double-Infection | 28 (5.88) |
No infection | 148 (31.09) |
Parasite species | ||||||||
---|---|---|---|---|---|---|---|---|
N |
Pf
|
TT
| HW |
GL
|
T.sp
|
SS
|
SM
| |
Age | ||||||||
< 5 | 74 | 39(52.7) | 2(2.7) | 0(0) | 1(2.5) | 4(10.25) | 0(0.0) | 1(2.5) |
5–14 | 402 | 223(55.7) | 0(0.00) | 2(0.89) | 6(2.6) | 10(4.48) | 1(0.45) | 11(4.9) |
P-Value | 0.000* |
0.992
|
0.993
|
0.989
|
0.993
|
0.992
|
0.964
| |
Male | 256 | 123(25.8) | 0 | 0 | 3(2.15 | 7(5.03) | 1(0.72) | 7(5.03) |
Female | 220 | 139(29.2) | 2(0.91) | 2(1.61) | 4(3.25 | 7(5.69) | 0(0.0) | 5(4.06) |
P-Value |
0.323
|
0.992
|
0.993
|
0.744
|
0.754
|
0.991
|
0.117
| |
Totals |
476
|
262
|
2
|
2
|
7
|
14
|
1
|
12
|
Predictor | Positive n (%) | Odds | P-value |
---|---|---|---|
Pf + GL
| 2(0.42) | 1.674 | 0.676 |
Pf + TT
| 1(0.21) | 1.00 | 0.991 |
Pf + SM
| 1(0.21) | 2.25 | 0.378 |
Pf + HW | 1(0.21) | 1.00 | 0.991 |
Pf + T.sp
| 5(1.05) | 14.13 | 0.019* |
Pf + SS
| 1(0.21) | 1.00 | 0.991 |
Predictor | Positive n (%) | Odds | P-value |
---|---|---|---|
PF
| 262(56.1) | 0.82 | 0.777 |
GL
| 7(1.47) | 1.00 | 0.984 |
TT
| 2(0.43) | 2.09 | 0.992 |
HW | 2(0.43) | 2.09 | 0.992 |
SM
| 12(2.52) | 1.10 | 0885 |
T.spp
| 14(2.94) | 2.62 | 0.085 |
SS
| 1(0.21) | 1.00 | 0.991 |
PF+ GL
| 6(1.26) | 0.66 | 0.707 |
PF + TT
| 2(0.43) | 1.00 | 0.992 |
PF + SM
| 12(2.52) | 1.11 | 0.874 |
PF + HW | 2(0.43) | 1.00 | 0.992 |
PF + T. spp
| 5(1.05) | 14.13 |
0.019*
|
PF + SS
| 1(0.21) | 1.00 | 0.991 |
Infection status | Positive (n) | Prevalence of Anaemia (%) |
---|---|---|
No Infection
| 148 | 24.1 |
Mono Infection
| 300 | 21.3 |
Co-infection
| 28 | 0.0 |